People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Medtronic names new diabetes exec: Pediatric endocrinologist Francine Kaufman will join Medtronic's diabetes business in June as VP of global medical affairs. Kaufman, who will report to the president of the diabetes unit Chris O'Connell, will be a "key architect of the company's global diabetes strategy, as well as a leading voice for multi-disciplinary medical strategy across Medtronic," firm said in a Nov. 24 announcement. She is and will remain a professor at the University of Southern California Keck School of Medicine and is a former president of the American Diabetes Association. Kaufman succeeds Alan Marcus
You may also be interested in...
People In Brief
Medtronic's DeMane goes VC: Former Medtronic Chief Operating Officer Michael DeMane joins health care venture capital firm Thomas, McNerney & Partners April 3. Thomas, McNerney's device portfolio includes atrial fibrillation firm Atritech and continuous glucose monitor developer ArKal Medical. DeMane, who had served in various executive roles with Medtronic since 2000, left the device giant last year when the firm elected to remove the COO position (1"The Gray Sheet" May 5, 2008, p. 4). He is the second big device company COO to move to the venture capital sector in the past three months, with Paul LaViolette leaving Boston Scientific for SV Life Sciences in January (2"The Gray Sheet" Dec. 22, 2008, p. 21)
People In Brief
Medtronic's DeMane goes VC: Former Medtronic Chief Operating Officer Michael DeMane joins health care venture capital firm Thomas, McNerney & Partners April 3. Thomas, McNerney's device portfolio includes atrial fibrillation firm Atritech and continuous glucose monitor developer ArKal Medical. DeMane, who had served in various executive roles with Medtronic since 2000, left the device giant last year when the firm elected to remove the COO position (1"The Gray Sheet" May 5, 2008, p. 4). He is the second big device company COO to move to the venture capital sector in the past three months, with Paul LaViolette leaving Boston Scientific for SV Life Sciences in January (2"The Gray Sheet" Dec. 22, 2008, p. 21)
People In Brief
Coapt Systems: Silicon Valley aesthetics firm appoints Laureen DeBueno as president and CEO Aug. 1. DeBueno has more than 25 years management experience in the medical device and technology markets, most recently as chief financial officer of Thermage. Coapt makes bioabsorbable implants for the fixation of soft tissue in the plastic, reconstructive and sports medicine markets